Get started
Author

Payam Abrishami

Observed names: Abrishami Shirazi, Payam, Abrishami, Payam, P Abrishami, P. Abrishami
ORCID: 0000-0002-4326-2938
Observed ORCID: 0000-0002-4326-2938
OpenAlex ID: A5039115137
Understanding the adoption dynamics of medical innovations: Affordances of the da Vinci robot in the Netherlands
2014 · Payam Abrishami, Albert Boer, et al. · Social Science & Medicine · 70
Pre-market Clinical Evaluations of Innovative High-risk Medical Devices in Europe
2012 · Frank Hulstaert, Mattias Neyt, et al. · International Journal of Technology Assessment in Health Care · 52
PDF
On the integration of early health technology assessment in the innovation process: reflections from five stakeholders
2020 · Marcia Tummers, Kari Kværner, et al. · International Journal of Technology Assessment in Health Care · 37
PDF
Defining early health technology assessment: building consensus using Delphi technique
2025 · Janneke P.C. Grutters, Janet Bouttell, et al. · International Journal of Technology Assessment in Health Care · 35
PDF
Moving Towards Accountability for Reasonableness – A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study
2019 · Monika Wagner, Dima Samaha, et al. · International Journal of Health Policy and Management · 32
PDF
Exploring Values of Health Technology Assessment Agencies Using Reflective Multicriteria and Rare Disease Case
2017 · Mireille M. Goetghebeur, Monika Wagner, et al. · International Journal of Technology Assessment in Health Care · 27
Best practice considerations on the assessment of robotic assisted surgical systems: results from an international consensus expert panel
2023 · Jamie Erskine, Payam Abrishami, et al. · International Journal of Technology Assessment in Health Care · 21
PDF
Standardized Reporting for Rapid Relative Effectiveness Assessments of Pharmaceuticals
2014 · Sarah Kleijnen, Iris Pasternack, et al. · International Journal of Technology Assessment in Health Care · 14
Ethics in HTA: Examining the "Need for Expansion"
2017 · Payam Abrishami, Wija Oortwijn, et al. · International Journal of Health Policy and Management · 13
PDF
Anticipating emerging medical technologies: The start of an international horizon scanning tool for medical devices
2024 · Renee Else Michels, Martinus Bertram de Graaff, et al. · Futures · 12
Nurturing Societal Values in and Through Health Innovations Comment on "What Health System Challenges Should Responsible Innovation in Health Address?"
2019 · Payam Abrishami, Sjoerd Repping · International Journal of Health Policy and Management · 12
When the Evidence Basis Breeds Controversies: Exploring the Value Profile of Robotic Surgery Beyond the Early Introduction Phase
2019 · Payam Abrishami, Albert Boer, et al. · Medical Care Research and Review · 12
Value in co creation: Subjecting innovative in hospital technologies to multi stakeholder appraisal
2017 · Abrishami, Payam, Boer, Albert, et al. · Research Publications (Maastricht University) · 12
How can we assess the value of complex medical innovations in practice?
2015 · Payam Abrishami, Albert Boer, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 12
PDF
An international consensus panel on the potential value of Digital Surgery
2024 · Jamie Erskine, Payam Abrishami, et al. · BMJ Open · 6
PDF
Piloting International Production of Rapid Relative Effectiveness Assessments of Pharmaceuticals
2014 · Sarah Kleijnen, Iris Pasternack, et al. · International Journal of Technology Assessment in Health Care · 5
The pre-market clinical evaluation of innovative high-risk medical devices
2011 · Frank Hulstaert, Mattias Neyt, et al. · 5
PDF
Generating Appropriate and Reliable Evidence for Value Assessment of Medical Devices: An ISPOR Medical Devices and Diagnostics Special Interest Group Report
2022 · Nneka C. Onwudiwe, Richard Charter, et al. · Journal of Medical Devices · 4
Da Vinci Surgery: Is it a No-Brainer? Robot-Assisted Prostate Surgery in the Mirror of Social Health Insurance
2012 · Payam Abrishami · SSRN Electronic Journal · 3
Evaluation clinique des dispositifs médicaux innovants à haut risque avant leur mise sur le marché
2011 · Frank Hulstaert, Mattias Neyt, et al. · 3
PDF
Accountable and Reasonable Processes for Coverage Decision-Making for Rare Disease and Regenerative Therapies – Which Criteria Should be Considered and Why?
2018 · M Wagner, D Samaha, et al. · Value in Health · 2
PP149 Features Of Accountable And Reasonable Processes For Coverage Decision-Making
2018 · Monika Wagner, Dima Samaha, et al. · International Journal of Technology Assessment in Health Care · 1
PDF
MT9 The Role of HTA Agencies in Relation to Medical Technologies: A Discourse Analysis
2023 · R. Michels, B. de Graaff, et al. · Value in Health
OP33 Expectations, Needs And Challenges Of Setting Up An International Collaboration On Horizon Scanning For Medical Devices
2022 · Renee Else Michels, Bert de Graaff, et al. · International Journal of Technology Assessment in Health Care
PDF
PMU73 Rewarding VALUE of Medical Technologies: VALUE-Based Access Programs (VBAPS) in Europe
2020 · P. Abrishami, R. Busca, et al. · Value in Health
Works count: 31
Citation count: 390
H-index: 12
I10-index: 14
Year
Topic
Type